Program & Downloads

Click here to download the entire book (680KB) –
To navigate in the pages, please use the search tool or the bookmarks.

Click here to see the speakers list

CONGRESS 2011

8:45 Introduction : Viral Hepatitis in 2011 - Patrick MARCELLIN (France)

8:45 – 10:45 Hepatitis C: towards a personalised management
Chairs :
Nezam AFDHAL (USA) Massimo LEVRERO (France)

8:55 Optimal use of virological tools - Stefan ZEUZEM (Germany) Download

9:15 Genetic markers: a major step for individualised care - John MCHUTCHISON (USA)

9:35 Impact of SVR on the long term outcome of the liver disease - Alfredo ALBERTI (Italy) Download

9:55 Serum markers or Fibroscan vs liver biopsy? - Laurent CASTERA (France) Download

10:15 Round table - All speakers

10:30 - 11:00 Coffee break

11:00 – 12:30 Optimising therapy in real life
Chairs :
Peter FERENCI (Austria) Jake LIANG (USA)

11:00 The role of triple therapy in genotype 1:

Naive patients - David NELSON (USA) Download

Experienced patients - Michael FRIED (USA) Download

11:30 Optimal therapy in non-1 genotypes:

Genotype 2 and 3 patients - Antonio CRAXI (Italy) Download

Genotype 4 patients - Sanaa KAMAL (Egypt) Download

12:00 Round table - All speakers

12:30 – 14:00 Interactive luncheons

Room 1

Non invasive markers of fibrosis : an easy access to treatment?

Chair: Nezam AFDHAL (USA)

Speakers:

Victor DE LEDINGHEN (France) Download

Ana Carolina CARDOSO (Brazil) Download

Room 2

Individualised approach to managing naive patients

Chair: Alfredo ALBERTI (Italy)

Speakers:

Gamal ESMAT (Egypt) Download

Philippe MATHURIN (France) Download

Room 3

Triple therapy: who and how?

Chair: Stefan ZEUZEM (Germany)

Speakers:

Christophe HEZODE (France) Download

Robert FLISIAK (Poland) Download

Room 4

Management of difficult to treat patients

Chair: Antonio CRAXI (Italy)

Speakers:

Jean-Pierre BRONOWICKI (France)

Marina BERENGUER (Spain) Download

Room 5

French speaking luncheon: Comment prendre en charge les patients atteints d’hépatite C?

Chair: Daniel DHUMEAUX (France)

Speakers:

Patrice COUZIGOU (France) Download

Najet BELHADJ BRIK (Tunisia) Download

14:00 – 15:45 New combinations
Chairs :
Marc BOURLIERE (France) Michael MANNS (Germany)

Advantages of new generation DAAs ? - Tarik ASSELAH (France) Download

Is ribavirin still useful? - Mitchell SHIFFMAN (USA)

Are interferons really necessary? - Edward GANE (New Zealand)) Download

14:45 Round table - All speakers

15:15 Clinical case: management of a non responder - Eugene SCHIFF (USA) Download

15:45 – 16:15 Coffee break

16:15 – 17:45 Management of Hepatocellular Carcinoma
Chairs :
Masao OMATA (Japan) Dominique VALLA (France)

16:15 Liver transplantation: expanding criteria? - Jacques BELGHITI (France) Download

16:30 Local regional approach - Josep LLOVET (Spain)

16:45 Novel molecular therapy - Eric RAYMOND (France) Download

17:00 How I manage my patients with hepatocellular carcinoma - Massimo COLOMBO (Italy) Download

17:15 The Zurich HCC liver transplantation consensus conference - Pierre-Alain CLAVIEN (Switzerland)

17:30 Round table - All speakers

18:00 – 18:30 Award ceremony
Chairman:
Patrick MARCELLIN (France)

Milestones and perspectives in hepatitis B - Stephanos HADZIYANNIS (Greece)

20:00 Congress dinner

8:30 – 10:00 Hepatitis B: towards a personalised management
Chairs :
Rafael ESTEBAN (Spain) Shiv KUMAR SARIN (India)

8:30 Impact of therapy on the long term outcome of liver disease - Yun-Fan LIAW (Taiwan)

8:45 Is resistance disappearing? - Fabien ZOULIM (France) Download

9:00 HBsAg: cvirologic significance - Maurizia BRUNETTO (Italy)

9:15 HBsAg: clinical relevance - Rami MOUCARI (United Arab Emirates) Download

9:30 Round table - All speakers

10:00 - 10:30 Coffee Break

10:30 – 11:30 HBeAg-positive chronic hepatitis B
Chairs :
Sam LEE (Canada) Jidong JIA (China)

10:30 Why do I treat my patient with a nucleos(t)ide analogue? - Nancy LEUNG (Hong Kong) Download

10:50 Why do I treat my patient with pegylated interferon? - Harry JANSSEN (The Netherlands) Download

11:10 Round table - All speakers

11:30 – 12:30 HBeAg-negative chronic hepatitis B
Chairs :
Geoffrey DUSHEIKO (UK) Feruccio BONINO (Italy)

11:30 Why do I treat my patient with a nucleos(t)ide analogue? - Georgios PAPATHEODORIDIS (Greece) Download

11:50 Why do I treat my patient with pegylated interferon? - Pietro LAMPERTICO (Italy) Download

12:10 Round table - All speakers

12:30 – 14:00 Interactive luncheons: regional management issues

Room 1

The role of HBsAg quantifi cation vs HBV DNA in clinical management of Hepatitis B

Chair: Sam LEE (Canada)

Speakers:

Maurizia BRUNETTO (Italy) Download

Teerha PIRATVISUTH (Thailand) Download

Room 2

Hepatocellular carcinoma. Asian vs European experience

Chair: Massimo COLOMBO (Italy)

Speakers:

Pierre-Alain CLAVIEN (Switzerland) Download

Masao OMATA (Japan)

Room 3

How to manage patients with resistant HBV

Chair: Marion PETERS (USA) Download

Speakers:

Maria BUTI (Spain) Download

Lawrence SERFATY (France) Download

Room 4

Active or inactive carrier: where is the frontier?

Chair: Thomas BERG (Germany)

Speakers:

Jean-Pierre ZARSKI (France) Download

Nancy LEUNG (Hong Kong) Download

Room 5

French speaking luncheon: Comment optimiser la prise en charge des patients AgHBe négatif?

Chair: Christian TREPO (France)

Speakers:

Mihai VOICULESCU (Romania)

Mustapha BENAZZOUZ (Morocco)

14:00 – 14:30 Clinical case: cirrhosis with lamivudine resistance - Marion PETERS (USA)

14:30 – 15:30 Special populations
Chairs :
Cihan YURDAYDIN (Turkey) Mario RIZZETTO (Italy)

14:30 HIV co-infection: does it make a difference? - Stanislas POL (France) Download

14:50 Difficulties faced in severe reactivation - Didier SAMUEL (France)

15:10 Hepatitis delta reviva - Heiner WEDEMEYER (Germany) Download

15:30 - 16:00 State of the Art lecture
Chairman:
Tarik ASSELAH (France)

State of the Art lecture - Arun SANYAL (USA) Download

Conclusion and perspectives - Patrick MARCELLIN (France)

Read articles from Liver